Literature DB >> 29577591

Effects of antigen removal on a porcine osteochondral xenograft for articular cartilage repair.

Steve Elder1, Hudson Chenault1, Paul Gloth1, Katie Webb1, Ruth Recinos1, Emily Wright1, Dalton Moran1, James Butler2, Abdolsamad Borazjani3, Avery Cooley4.   

Abstract

Given the limited availability of fresh osteochondral allografts and uncertainty regarding performance of decellularized allografts, this study was undertaken as part of an effort to develop an osteochondral xenograft for articular cartilage repair. The purpose was to evaluate a simple antigen removal procedure based mainly on treatment with SDS and nucleases. Histology demonstrated a preservation of collagenous structure and removal of most nuclei. Immunohistochemistry revealed the apparent retention of α-Gal within osteocyte lacunae unless the tissue underwent an additional α-galactosidase processing step. Cytoplasmic protein was completely removed as shown by Western blot. Quantitatively, the antigen removal protocol was found to extract approximately 90% of DNA from cartilage and bone, and it extracted over 80% of glycosaminoglycan from cartilage. Collagen content was not affected. Mechanical testing of cartilage and bone were performed separately, in addition to testing the cartilage-bone interface, and the main effect of antigen removal was an increase in cartilage hydraulic permeability. In vivo immunogenicity was assessed by subcutaneous implantation into DBA/1 J mice, and the response was typical of a foreign body rather than immune reaction. Thus, an osteochondral xenograft produced as described has the potential for further development into a treatment for osteochondral lesions in the human knee.
© 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2251-2260, 2018. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  antigen removal; biomechanics; immunogenicity; osteochondral xenograft; α-Gal

Mesh:

Substances:

Year:  2018        PMID: 29577591      PMCID: PMC6779129          DOI: 10.1002/jbm.a.36411

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  36 in total

1.  Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts.

Authors:  Roberta H Raeder; Stephen F Badylak; Christine Sheehan; Bhaskar Kallakury; Dennis W Metzger
Journal:  Transpl Immunol       Date:  2002-06       Impact factor: 1.708

2.  Pig xenogeneic antigen modification with green coffee bean alpha-galactosidase.

Authors:  Y Luo; J Wen; C Luo; R D Cummings; D K Cooper
Journal:  Xenotransplantation       Date:  1999-11       Impact factor: 3.907

3.  Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study.

Authors:  Jolene E Valentin; John S Badylak; George P McCabe; Stephen F Badylak
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

4.  A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1,3)-galactose and retention of matrix structure.

Authors:  Hui Xu; Hua Wan; Wenqi Zuo; Wendell Sun; Rick T Owens; John R Harper; David L Ayares; David J McQuillan
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

5.  Development and characterization of an acellular porcine cartilage bone matrix for use in tissue engineering.

Authors:  Ehab Kheir; Thomas Stapleton; David Shaw; Zhongmin Jin; John Fisher; Eileen Ingham
Journal:  J Biomed Mater Res A       Date:  2011-08-19       Impact factor: 4.396

6.  High Failure Rate of a Decellularized Osteochondral Allograft for the Treatment of Cartilage Lesions.

Authors:  Jack Farr; Guilherme C Gracitelli; Nehal Shah; Eric Y Chang; Andreas H Gomoll
Journal:  Am J Sports Med       Date:  2016-05-13       Impact factor: 6.202

7.  Differences in xenoreactive immune response and patterns of calcification of porcine and bovine tissues in α-Gal knock-out and wild-type mouse implantation models.

Authors:  Min-Seok Kim; Saeromi Jeong; Hong-Gook Lim; Yong Jin Kim
Journal:  Eur J Cardiothorac Surg       Date:  2014-12-30       Impact factor: 4.191

8.  Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.

Authors:  Erwin Rieder; Gernot Seebacher; Marie-Theres Kasimir; Eva Eichmair; Birgitta Winter; Barbara Dekan; Ernst Wolner; Paul Simon; Guenter Weigel
Journal:  Circulation       Date:  2005-05-23       Impact factor: 29.690

Review 9.  Antigen removal for the production of biomechanically functional, xenogeneic tissue grafts.

Authors:  Derek D Cissell; Jerry C Hu; Leigh G Griffiths; Kyriacos A Athanasiou
Journal:  J Biomech       Date:  2013-11-08       Impact factor: 2.712

Review 10.  Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.

Authors:  M S Sandrin; I F McKenzie
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

View more
  2 in total

1.  A Systematic Review and Guide to Mechanical Testing for Articular Cartilage Tissue Engineering.

Authors:  Jay M Patel; Brian C Wise; Edward D Bonnevie; Robert L Mauck
Journal:  Tissue Eng Part C Methods       Date:  2019-09-30       Impact factor: 3.056

2.  Supercritical Carbon Dioxide Decellularized Xenograft-3D CAD/CAM Carved Bone Matrix Personalized for Human Bone Defect Repair.

Authors:  Meng-Yen Chen; Jing-Jing Fang; Jeng-Nan Lee; Srinivasan Periasamy; Ko-Chung Yen; Hung-Chou Wang; Dar-Jen Hsieh
Journal:  Genes (Basel)       Date:  2022-04-25       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.